论文信息 - Cost-effectiveness thresholds in the USA: are they coming? Are they already here? - 字舞流文

Cost-effectiveness thresholds in the USA: are they coming? Are they already here?

[1] John B. Watkins,et al. Design, implementation, and first-year outcomes of a value-based drug formulary. , 2015, Journal of managed care & specialty pharmacy.

[2] G. Fonarow,et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Circulation.

[3] S. Kaplan,et al. Who Can Respond to Treatment?: Identifying Patient Characteristics Related to Heterogeneity of Treatment Effects , 2010, Medical care.

[4] Dan Greenberg,et al. Is the United States ready for QALYs? , 2009, Health affairs.

[5] M. Kamlet,et al. QALYs: some challenges. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[6] S. Teutsch,et al. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services. , 2001, American journal of preventive medicine.